Glaucoma, Alzheimer Disease and Other Dementia: A Longitudinal Analysis

REFERENCES

• Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med 2009;360(11):1113–1124.
   PubMed Web of Science ®Google Scholar
• Whitcup SM. Clinical trials in neuroprotection. Prog Brain Res 2008;173:323–335.
   PubMed Web of Science ®Google Scholar
• Sloane PD, Zimmerman S, Suchindran C, et al. The public health impact of Alzheimer’s disease, 2000–2050: potential implication of treatment advances. Annu Rev Public Health 2002;23:213–231.
   PubMed Web of Science ®Google Scholar
• Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet 2006;368(9533):387–403.
   PubMed Web of Science ®Google Scholar
• Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985;82(12):4245–4249.
   PubMed Web of Science ®Google Scholar
• Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83(13):4913–4917.
   PubMed Web of Science ®Google Scholar
• Bu G. Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 2009;10(5):333–344.
   PubMed Web of Science ®Google Scholar
• Vickers JC, Craig JE, Stankovich J, et al. The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis Oct 14 2002;8:389–393.
   PubMed Web of Science ®Google Scholar
• Zetterberg M, Tasa G, Palmer MS, et al. Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma. Am J Ophthalmol 2007;143(6):1059–1060.
   PubMed Web of Science ®Google Scholar
• Copin B, Brezin AP, Valtot F, Dascotte JC, Bechetoille A, Garchon HJ. Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet 2002;70(6):1575–1581.
   PubMed Web of Science ®Google Scholar
• Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med 1986;315(8):485–487.
   PubMed Web of Science ®Google Scholar
• Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer’s disease. Ophthalmology 1990;97(1):9–17.
   PubMed Web of Science ®Google Scholar
• Tsai CS, Ritch R, Schwartz B, et al. Optic nerve head and nerve fiber layer in Alzheimer’s disease. Arch Ophthalmol 1991;109(2):199–204.
   PubMedGoogle Scholar
• McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 2002;43(4):1077–1087.
   PubMed Web of Science ®Google Scholar
• Guo L, Salt TE, Luong V, et al. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci USA 2007;104(33):13444–13449.
   PubMed Web of Science ®Google Scholar
• Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer’s disease. Eur Neurol 2002;47(3):165–168.
   PubMed Web of Science ®Google Scholar
• Bayer AU, Keller ON, Ferrari F, Maag KP. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer’s disease and Parkinson’s disease. Am J Ophthalmol 2002;133(1):135–137.
   PubMed Web of Science ®Google Scholar
• Tamura H, Kawakami H, Kanamoto T, et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer’s disease. J Neurol Sci 2006;246(1–2):79–83.
   PubMed Web of Science ®Google Scholar
• Kessing LV, Lopez AG, Andersen PK, Kessing SV. No increased risk of developing Alzheimer disease in patients with glaucoma. J Glaucoma 2007;16(1):47–51.
   PubMed Web of Science ®Google Scholar
• Ukraintseva S, Sloan F, Arbeev K, Yashin A. Increasing rates of dementia at time of declining mortality from stroke. Stroke 2006;37(5):1155–1159.
   PubMed Web of Science ®Google Scholar
• D’Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics Med 1998;17(19):2265–2281.
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70(1):41–55.
   Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373–383.
   PubMedGoogle Scholar
• Manitoba Centre for Health Policy. Concept: Charlson Index; 2009. Accessed May 27, 2001 from: http://mchp-appserv.cpe.umanitoba.ca/viewConcept.php?conceptID = 1098
   Google Scholar
• Parsons LS. Reducing Bias in Propensity Score Matched-Pair Sample Using Greedy Matching Techniques. Seattle, WA.
   Google Scholar
• Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thoracic Cardiovasc Surg 2007;134:1128–1135, 1135.e1121–1135.e1123.
   PubMed Web of Science ®Google Scholar
• Normand SL, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 2001;54:387–398.
   PubMed Web of Science ®Google Scholar
• Chandra V, Bharucha NE, Schoenberg BS. Conditions associated with Alzheimer’s disease at death: case-control study. Neurology 1986;36(2):209–211.
   PubMed Web of Science ®Google Scholar
• Schwartzbaum J, Ahlbom A, Feychting M. Berkson’s Bias reviewed. Eur J Epidemiol 2003;18(12):1109–1112.
   PubMed Web of Science ®Google Scholar
• Rubin GS, West SK, Munoz B, et al. A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci 1997;38(3):557–568.
   PubMed Web of Science ®Google Scholar
• Munoz B, West S, Rubin GS, Schein OD, Fried LP, Bandeen-Roche K. Who participates in population based studies of visual impairment? The Salisbury Eye Evaluation project experience. Ann Epidemiol 1999;9(1):53–59.
   PubMed Web of Science ®Google Scholar
• Baker ML, Wang JJ, Rogers S, et al. Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study. Arch Ophthalmol 2009;127(5):667–673.
   PubMedGoogle Scholar
• Klaver CCW, Ott A, Hofman A, Assink JJM, Breteler MMB, de Jong P. Is age-related maculopathy associated with Alzheimer’s disease? The Rotterdam Study. Am J Epidemiol 1999;150(9):963–968.
   PubMed Web of Science ®Google Scholar
• Harding JJ. Cataract, Alzheimer’s disease, and other conformational diseases. Curr Opin Ophthalmol 1998;9(1):10–13.
   PubMedGoogle Scholar
• Goldstein LE, Muffat JA, Cherny RA, et al. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer’s disease. Lancet 2003;361(9365):1258–1265.
   PubMed Web of Science ®Google Scholar
• Bjorkdahl C, Sjogren MJ, Zhou X, et al. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments. J Neurosci Res 2008;86(6):1343–1352.
   PubMed Web of Science ®Google Scholar
• Demirovic J, Prineas R, Loewenstein D, et al. Prevalence of dementia in three ethnic groups: The South Florida Program on Aging and Health. Ann Epidemiol 2003;13(6):472–478.
   PubMed Web of Science ®Google Scholar
• Fillenbaum GG, Heyman A, Huber MS, et al. The prevalence and 3-year incidence of dementia in older Black and White community residents. J Clin Epidemiol 1998;51(7):587–595.
   PubMed Web of Science ®Google Scholar
• Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population − Prevalence estimates using the 2000 census. Arch Neurol 2003;60(8):1119–1122.
   PubMedGoogle Scholar
• Husaini BA, Sherkat DE, Moonis M, Levine R, Holzer C, Cain VA. Racial differences in the diagnosis of dementia and in its effects on the use and costs of health care services. Psychiatric Services 2003;54(1):92–96.
   PubMed Web of Science ®Google Scholar
• Tang MX, Cross P, Andrews H, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001;56(1):49–56.
   PubMed Web of Science ®Google Scholar
• Clark PC, Kutner NG, Goldstein FC, et al. Impediments to timely diagnosis of Alzheimer’s disease in African Americans. J Am Geriatr Soc 2005;53(11):2012–2017.
   PubMed Web of Science ®Google Scholar
• Shadlen MF, Siscovick D, Fitzpatrick AL, Dulberg C, Kuller LH, Jackson S. Education, cognitive test scores, and black-white differences in dementia risk. J Am Geriatr Soc 2006;54(6):898–905.
   PubMed Web of Science ®Google Scholar
• Taylor DH, Jr., Fillenbaum GG, Ezell ME. The accuracy of Medicare claims data in identifying Alzheimer’s disease. J Clin Epidemiol 2002;55(9):929–937.
   PubMed Web of Science ®Google Scholar